NEA Secondary — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Sorriso Pharmaceuticals, Inc.Jan 2022SEC filingmedium confidence
BiotechSandy, US
Ciara Kennedy, Ph.D.(Executive Officer, Director)Brian Dorsey(Executive Officer)Michael Grey(Director)Mark Chin(Director)Susan Dube(Executive Officer)
Board seatEdward Mathers· per SEC Form D · $31.4M raise · filed Jan 2022
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.